EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Percutaneous Ethanol Ablation of Parathyroid Adenoma and Parathyroidectomy Are Comparable

Iraj Heydari iD, Sara Golmohammadi iD, Mohammad Reza Babaei iD, Hamed Iraji iD, Hossein Akhondi iD

International Journal of Endocrinology · 2026-01 · 2026 (1)

DOI: 10.1155/ije/4939126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Endocrinology, online erschienen am 05.07.2026. Verfasst von Iraj Heydari und 4 weiteren Autor:innen. Beteiligte Einrichtung: Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran, iums.ac.ir. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To compare ethanol injection of parathyroid adenoma with surgical parathyroidectomy (PTX).

Methods

A prospective, partially randomized preference clinical trial of two groups assigned to surgical PTX (20 patients) or ethanol injection (PEA) (10 patients). The inequality was due to patient preferences and limitations caused by the coronavirus pandemic.

Results

Both PEA and PTX resulted in 80% or more of patients having normalized calcium levels after one month. These were sustained through 6 months. A significant proportion of patients after both PEA and PTX had normalized PTH levels after one month (55% and 70%, respectively), which remained unchanged at the 3‐ and 6‐month measurements. After 12 months, calcium and parathyroid hormone levels were lower in the PTX group, while phosphorus levels were higher; however, the differences were not statistically significant. Complications were more common in the PTX group, although the difference was not statistically significant.

Conclusion

Overall, PEA and PTX have similar outcomes. Although not statistically significant, the PEA of parathyroid adenoma causes a less pronounced effect on calcium and parathyroid hormone levels and has fewer side effects.

Autor:innen und Institutionen

  • Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran, iums.ac.ir.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran, iums.ac.ir.
  • Interventional Radiology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran, iums.ac.ir.
  • Graduate Medical Education, University of Nevada, Reno, Nevada, USA, unlv.edu.

ORCID-Profile: Iraj Heydari, Sara Golmohammadi, Mohammad Reza Babaei, Hamed Iraji, Hossein Akhondi

Zitieren

APA

Heydari, I., Golmohammadi, S., Babaei, M. R., Iraji, H., & Akhondi, H. (2026). Percutaneous Ethanol Ablation of Parathyroid Adenoma and Parathyroidectomy Are Comparable. International Journal of Endocrinology, 2026(1). https://doi.org/10.1155/ije/4939126

Vancouver

Heydari I, Golmohammadi S, Babaei MR, Iraji H, Akhondi H. Percutaneous Ethanol Ablation of Parathyroid Adenoma and Parathyroidectomy Are Comparable. International Journal of Endocrinology. 2026;2026(1). doi:10.1155/ije/4939126

BibTeX
@article{Heydari2026,
  author = {Heydari, Iraj and Golmohammadi, Sara and Babaei, Mohammad Reza and Iraji, Hamed and Akhondi, Hossein},
  title = {Percutaneous Ethanol Ablation of Parathyroid Adenoma and Parathyroidectomy Are Comparable},
  journal = {International Journal of Endocrinology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/ije/4939126}
}
Kostenlos starten →